Kurt Gebauer

6PUBLICATIONS
22CO-AUTHORS
Haematological tumoursTransport properties and non-equilibrium processesClinical pharmacology and therapeuticsGene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 09, 2026
Retrospective Analysis of the Recurrence of Atypical Fibroxanthoma When Treated With Curettage and Cautery at a Single Centre.

Nehel Binte-Mehdi Syed, Kurt Gebauer

|Dec 29, 2025
Delayed Bullous Drug Eruption Induced by Elexacaftor/Tezacaftor/Ivacaftor.

Tatiana Ninkov, Megan Yap, Nima Mesbah Ardakani

|Aug 05, 2025
Guidelines for Phototherapy and PUVA Service Delivery in Australia: Minimum Standards and Quality Assurance Framework.

Stephanie Tan, Kurt GeBauer

|May 14, 2025
Consensus on the Use of JAKinibs for Atopic Dermatitis in Australia and New Zealand. An eDelphi by the Australasian Medical Dermatology Group.

Marius Rademaker, Peter Foley, Katherine Armour

|Dec 31, 2024
Efficacy and Safety of Switching From Intravenous to Subcutaneous Infliximab for Psoriasis: A Case Series.

Conor Larney, Peter Foley, Kurt Gebauer

|Jul 28, 2023
Australian consensus: Treatment goals for moderate to severe psoriasis in the era of targeted therapies - Adult patients.

Peter Foley, Kurt Gebauer, John Sullivan

Pageof 1